Brii Biosciences Announces Two Breakthrough Therapy Designat

Brii Biosciences Announces Two Breakthrough Therapy Designations for BRII-877 and BRII-835 Building on Extensive Clinical Evidence from Multiple Phase 2 Studies

Brii Biosciences Announces Two Breakthrough Therapy Designations for BRII-877 and BRII-835 Building on Extensive Clinical Evidence from Multiple Phase 2 Studies

prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

China , Shanghai , Beijing , Qing Zhu , Hunan , Brii Bio , Brii Biosciences Limited Bio , Nasdaq , Vaccines Inc , Vir Biotechnology Inc , Hepatitisd World Health Organization , National Medical Products Administration , World Health Organization , Brii Biosciences , Brii Biosciences Limited , Drug Evaluation , Breakthrough Therapy Designations , Breakthrough Therapy Designation , Vir Biotechnology , Enhanced Stabilization Chemistry Plus , Biosciences Limited , San Francisco Bay Area , World Health ,